COVID-19Top StoryUS

US to recommend COVID vaccine boosters regardless of age

COVID

In a move many have seen coming, U.S. health experts are going to recommend Americans get a booster 8 months after receiving a second dose. All the definite effectiveness touted by many in government of COVID-19 vaccine research is not as complete as many Americans have suspected. The Associated Press has the story:

Many U.S. health officials are expressing that the time for booster shots is coming sooner rather than later

WASHINGTON (AP) — U.S. health experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country.

FILE – A man gets a COVID-19 vaccine at a mass vaccination site at the Natick Mall on Wednesday, Feb. 24, 2021, in Natick, Mass. U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country. An announcement was expected as soon as this week, with doses beginning to be administered widely once the Food and Drug Administration formally approves the vaccines. (Matt Stone/The Boston Herald via AP, Pool)

Federal health officials have been actively looking at whether extra shots for the vaccinated would be needed as early as this fall, reviewing case numbers in the U.S. as well as the situation in other countries such as Israel, where preliminary studies suggest the vaccine’s protection against serious illness dropped among those vaccinated in January.

An announcement on the U.S. booster recommendation was expected as soon as this week, according to two people familiar with the matter who spoke to The Associated Press on the condition of anonymity to discuss internal deliberations.

Doses would only begin to be administered widely once the Food and Drug Administration formally approves the vaccines. That action is expected for the Pfizer shot in the coming weeks.

Last week, U.S. health officials recommended boosters for some with weakened immune systems, citing their higher risk of catching the virus and evidence that the vaccines’ effectiveness waned over time.

The director of the National Institutes of Health, Dr. Francis Collins, said Sunday the U.S. could decide in the next couple weeks whether to offer coronavirus booster shots to Americans this fall.

FILE – A pharmacy technician loads a syringe with Pfizer’s COVID-19 vaccine, Tuesday, March 2, 2021, at a mass vaccination site at the Portland Expo in Portland, Maine. U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country. An announcement was expected as soon as this week, with doses beginning to be administered widely once the Food and Drug Administration formally approves the vaccines. (AP Photo/Robert F. Bukaty)

Among the first to receive them could be health care workers, nursing home residents and other older Americans, who were some of the first Americans to be vaccinated once the shots received emergency use authorization last December.

Since then, more than 198 million Americans have received at least one dose of a COVID-19 vaccine according to the Centers for Disease Control and Prevention, with more than 168 million fully vaccinated. Still, the country is experiencing a fourth surge of virus cases due to the more transmissible delta variant, which is spreading aggressively through unvaccinated communities but is also responsible for an increasing number of so-called “breakthrough infections” of fully vaccinated people.

Israel, which exclusively administered the Pfizer shot, has been offering a coronavirus booster to people over 60 who were already vaccinated more than five months ago in an effort to control its own surge in cases from the delta variant.

FILE – In this Jan. 28, 2021, file photo, doses of the Moderna COVID-19 vaccine sit in a tray of a pharmacy station at the Hamilton County Health Department’s new COVID-19 Vaccination POD at the CARTA Bus Terminal in Chattanooga, Tenn. Despite having some of the lowest COVID-19 vaccination rates in the country, Tennessee isn’t planning to offer any incentives for people to get the shot. But it’s a different story when it comes to cattle, where the state has reimbursed farmers nearly half a million dollars over the past two years to vaccinate their herds against respiratory and other diseases. (Troy Stolt/Chattanooga Times Free Press via AP, File)

For months, officials had said data still indicated that people remain highly protected from COVID-19, including the delta variant, after receiving the two-dose Pfizer or Moderna regimen or the one-shot Johnson & Johnson vaccine. But U.S. health officials made clear Sunday they are preparing for the possibility that the time for boosters may come sooner than later.

“There is a concern that the vaccine may start to wane in its effectiveness,” Collins said. “And delta is a nasty one for us to try to deal with. The combination of those two means we may need boosters, maybe beginning first with health care providers, as well as people in nursing homes, and then gradually moving forward” with others, such as older Americans who were among the first to get vaccinations.

FDA
In this March 2021 photo provided by Pfizer, vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company’s facility in Puurs, Belgium. Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday, July 8, 2021, that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant. (Pfizer via AP)

He said because the delta variant only started hitting the U.S. hard in July, the “next couple of weeks” of case data will help the U.S. make a decision.

Officials were continuing to collect information as well about the J&J vaccine, which was only approved in the U.S. in late February, to determine when to recommend boosters, one of the officials said.

Activists wearing masks depicting Chancellor Merkel and U.S. President Biden stand in front of a symbolic “patent wall” that they are smashing with hammers in Berlin, Germany, Wednesday, July 14, 20221. The wall reads “Covid 19 Peoples Vaccine.” Avaaz activists are calling for the temporary suspension of patent protection for Covid vaccines. (Fabian Sommer/dpa via AP)

The White House has said that even though the U.S. has begun sharing more than 110 million vaccine doses with the world, the nation has enough domestic supply to deliver boosters to Americans should they be recommended by health officials.

Global health officials, including the World Health Organization, have called on wealthier and more-vaccinated countries to hold off on booster shots to ensure the supply of first doses for people in the developing world.

Byline:  By ZEKE MILLER

For more U.S. and world news

Previous Article
Robert Durst admits he wrote ‘cadaver’ note to police
Next Article
Factory production better than ever last four months

How useful was this article?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this article.

Latest News

Menu